Trulieve Cannabis (TCNNF) Non-Current Debt (2020 - 2026)
Trulieve Cannabis (TCNNF) recorded quarterly Non-Current Debt of $90.1 million in Q1 2026, down 0.81% quarter-over-quarter from $90.8 million in Q4 2025, and down 18.93% on a YoY basis from $111.1 million in Q1 2025.
Trulieve Cannabis (TCNNF) Non-Current Debt (2020 - 2026) Analysis & Trends
Trulieve Cannabis' Non-Current Debt history runs 7 years deep, the most recent figure standing at $90.1 million for Q1 2026.
- In Q1 2026, Non-Current Debt fell 18.93% year-over-year to $90.1 million; the TTM figure through Mar 2026 stood at $90.1 million (down 18.93% YoY), while the FY2025 annual figure was $90.8 million, down 18.85% from the prior year.
- Non-Current Debt was $90.1 million for Q1 2026 at Trulieve Cannabis, down from $90.8 million in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $115.9 million in Q4 2023 to a low of $3.4 million in Q2 2022.
- Historically, Non-Current Debt has averaged $86.2 million across 5 years, with a median of $94.2 million in 2022.
- The sharpest annual moves came in 2023 and 2026: Non-Current Debt soared 2606.2% in 2023, then dropped 18.93% in 2026.
- A 5-year view of Non-Current Debt shows it stood at $94.2 million in 2022, then climbed by 22.93% to $115.9 million in 2023, then fell by 3.37% to $111.9 million in 2024, then slipped by 18.85% to $90.8 million in 2025, then slipped by 0.81% to $90.1 million in 2026.
- The last three Non-Current Debt figures came in at $90.1 million (Q1 2026), $90.8 million (Q4 2025), and $107.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 14.02 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 9.05 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 3.92 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.48 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 569.60 Mn |
| 10 | Trulieve Cannabis | - | - | 170.08 Mn | 90.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 90.10 Mn |
| Mar 31, 2026 | 90.10 Mn |
| Dec 31, 2025 | 90.84 Mn |
| Dec 31, 2025 | 90.84 Mn |
| Sep 30, 2025 | 107.67 Mn |
| Sep 30, 2025 | 107.67 Mn |
| Jun 30, 2025 | 108.52 Mn |
| Jun 30, 2025 | 108.52 Mn |
| Mar 31, 2025 | 111.14 Mn |
| Mar 31, 2025 | 111.14 Mn |
| Dec 31, 2024 | 111.95 Mn |
| Dec 31, 2024 | 111.95 Mn |
| Sep 30, 2024 | 112.76 Mn |
| Sep 30, 2024 | 112.76 Mn |
| Jun 30, 2024 | 113.51 Mn |
| Jun 30, 2024 | 113.51 Mn |
| Mar 31, 2024 | 115.01 Mn |
| Mar 31, 2024 | 115.01 Mn |
| Dec 31, 2023 | 115.86 Mn |
| Dec 31, 2023 | 115.86 Mn |